03.05.2015 Views

Here - EWMA 2013

Here - EWMA 2013

Here - EWMA 2013

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

POSTER PRESENTATIONS<br />

P 356<br />

Poster: Case Study<br />

MANAGEMENT OF A LYMPHEDEMA PATIENT WITH A TWO COMPONENT RIGID<br />

COMPRESSION SYSTEM – A CASE STUDY<br />

Ria van Dam 1 , Alice van den Wijngaard 2<br />

1 Boerhaave Foundation for Nursing homes, location: St. Jacob (Haarlem, Netherlands);<br />

2 Lohmann & Rauscher (Almere, Netherlands).<br />

Aim: Lymphedema may be caused by phlebological disorders, trauma, surgery or<br />

oncology. Therapy is delivered by a multi-disciplinary team and comprises: skin care;<br />

exercise; high stiffness compression (SSI >10) and lymph drainage therapy. Patient<br />

guidance, education and motivation is key in the delivery of lymphedema treatment.<br />

The aim of this case study was to provide improvement of the patients ‘quality of life,<br />

achieving complete debridement, closing the lesions and providing comfortable and<br />

effective lymphedema management.<br />

Method: Case ascertainment was used in the 84 year-old male patient with combined<br />

venous lymphatic lesions, blisters and massive oedema in both lower legs and feet. The<br />

lesions appear infected with Pseudomonas aeruginosa. The complete regime was<br />

revised, using a *monofilament debrider wetted with PHMB for debridement of the<br />

lesions and removal of scabs; a **non-adhesive foam dressing and a less bulky ***two<br />

component compression system. The toes were included in the compression bandage<br />

and specialist lymphedema footwear was used.<br />

Results: After one week the skin lesions had closed and the oedema reduction was 9,6<br />

cm (measured at the calf). Compression with the two component system was continued<br />

for another three weeks, after which he received a ****tubular compression system for<br />

maintenance therapy, continuing with skin care and specialist footwear.<br />

Conclusion: The treatment regime allowed for fast closure of the lesions and effective<br />

reduction of the lymphedema in a patient-friendly manner, improving the patients<br />

mobility and quality of life.<br />

*Debrisoft<br />

**Suprasorb ® P<br />

***Rosidal ® TCS<br />

****Actico Silk, Lohmann & Rauscher<br />

POSTER: CASE STUDY<br />

P 357<br />

Poster: Case Study<br />

COMPLEX CASE SERIES OF FOUR DIFFERENT STAGNATING WOUND TYPES<br />

TREATED WITH A COLLAGEN DRESSING<br />

Stella Amesz 1 , A van Zandbergen 1<br />

1 Wond Expertise Centrum en Zorg Brug (Gouda, Netherlands).<br />

Aim: Efficacy of a *collagen dressing on inflammation reduction and re-starting healing<br />

was evaluated in four patients with stagnating wounds of different aetiologies.<br />

Methods: Case ascertainment was used. Patients had a mean age of 59 years (SD ±<br />

23,19) Patients received a *collagen dressing and a **foam or an ***alginate as a<br />

secondary dressing, for a maximum of 14 days, after which the collagen dressing was<br />

discontinued and the foam used as a primary dressing. Wound healing was assessed<br />

using clinical observation and digital photographs, comparing day 0 versus day 14<br />

results. Patients were then followed until wound closure.<br />

Results: Patient 1: Mentally retarded 19-year-old male with a stagnating stage three<br />

sacral pressure ulcer. After three weeks signs of healing were evident and wound<br />

closure was achieved in 12 weeks. Patient 2: Sixty-nine year old frail female with<br />

multiple pathologies who had a stagnating wound after knee implant surgery. After three<br />

weeks of collagen dressing use her wound improved and went on to healing within 30<br />

weeks. Patient 3 and 4 underwent a resection of a facial basal cell carcinoma which<br />

resulted in a stagnating wound, after skin grafting failed. The wound of patient 3 was<br />

closed within 14 weeks and for patient 4 healing was achieved within 14 days.<br />

Conclusion: The case series results indicate the use of collagen to effectively start up<br />

the stagnating healing process.<br />

*Suprasorb ® C<br />

**Suprasorb ® P<br />

***Suprasorb ® A, Lohmann & Rauscher<br />

208

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!